SYNDROME OF BURNED SKIN IMPROVEMENTS IN TREATMENT AND DIAGNOSIS

Abstract

Background: Staphylococcus aureus produces epidermolytic toxins that disrupt epidermal cell connections, resulting in staphylococcal scalded skin syndrome (SSSS). Blisters, erythematous cellulitis, and superficial skin peeling characterize this condition.

Objective: To provide an overview of the clinical foundation, etiopathogenesis, complications, current treatment options, and potential future advancements in managing SSSS.

Methods: This review synthesizes available data on the pathogenesis, clinical manifestations,  differential diagnoses, and therapeutic interventions for SSSS.

Results: It is classified as a toxin-mediated infection, primarily affecting adults and pediatric patients. Key therapeutic interventions include:

1. Wound care to protect damaged skin.
2. Antibiotic therapy with antistaphylococcal medications.
3. Supportive care with analgesia.

Differential diagnoses such as toxic epidermal necrolysis, adverse drug reactions, and Stevens-Johnson syndrome require multidisciplinary evaluation by dermatologists, infectious disease specialists, and surgeons.

Conclusion: Effective management of SSSS involves a multidisciplinary approach to reduce mortality. Future developments may enhance understanding and treatment outcomes for this toxin-mediated disease.